Biotech · Public company · Needham, MA, US

Candel Therapeutics, Inc.

Ticker CADL · SEC CIK 0001841387

Track this companyFree. Adds Candel Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials146 recruiting or active

Pipeline programs32From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline32

Aglatimagene BesadenovecPhase 3 · Non-squamous, Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Aglatimagene besadenovec + valacyclovirPhase 3 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 3 · Non-squamous, Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Non-squamous, Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
ValacyclovirPhase 3 · Non-squamous, Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
aglatimagene besadenovecPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Aglatimagene besadenovecPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Aglatimagene besadenovecPhase 2 · Borderline Resectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
aglatimagene besadenovec + valacyclovirPhase 2 · Prostate Cancer Patients Treated by RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
CAN-2409Phase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
ChemoradiationPhase 2 · Borderline Resectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
ChemotherapyPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
External Beam Radiation Therapy (EBRT)Phase 2 · Prostate Cancer Patients Treated by RadiotherapyClinicalTrials.gov · fetched Nov 12, 2026
Radiation therapyPhase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
Stereotactic body radiation therapyPhase 2 · Borderline Resectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
SurgeryPhase 2 · Borderline Resectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
TemozolomidePhase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
valacyclovirPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
ValacyclovirPhase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
ValacyclovirPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
AdV-tkPhase 1 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
AdV-tkPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
AdV-tkPhase 1 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
AdV-tk + valacyclovirPhase 1 · Malignant Pleural EffusionClinicalTrials.gov · fetched Nov 12, 2026
CAN-2409 + valacyclovirPhase 1 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Laboratory Biomarker AnalysisPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
RadiationPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
RadiationPhase 1 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
TemozolomidePhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
ValacyclovirPhase 1 · Glioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
ValacyclovirPhase 1 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials14

Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07660094 · fetched Nov 12, 2026
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPHASE2 · RECRUITING · started Oct 30, 2025ClinicalTrials.gov NCT07332000 · fetched Nov 12, 2026
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLCPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 13, 2020ClinicalTrials.gov NCT04495153 · fetched Nov 12, 2026
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade GliomasPHASE1 · COMPLETED · started Feb 27, 2018ClinicalTrials.gov NCT03576612 · fetched Nov 12, 2026
A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2PHASE1 · ACTIVE_NOT_RECRUITING · started Jul 18, 2017ClinicalTrials.gov NCT03152318 · fetched Nov 12, 2026
Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung CancerPHASE1 · COMPLETED · started May 4, 2017ClinicalTrials.gov NCT03131037 · fetched Nov 12, 2026
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)PHASE2 · ACTIVE_NOT_RECRUITING · started May 1, 2016ClinicalTrials.gov NCT02768363 · fetched Nov 12, 2026
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic AdenocarcinomaPHASE2 · UNKNOWN · started Oct 1, 2015ClinicalTrials.gov NCT02446093 · fetched Nov 12, 2026
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionPHASE1 · COMPLETED · started Oct 1, 2013ClinicalTrials.gov NCT01997190 · fetched Nov 12, 2026
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 1, 2011ClinicalTrials.gov NCT01436968 · fetched Nov 12, 2026
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsPHASE1 · COMPLETED · started Oct 1, 2010ClinicalTrials.gov NCT00634231 · fetched Nov 12, 2026
AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)PHASE1 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00638612 · fetched Nov 12, 2026
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant GliomaPHASE2 · COMPLETED · started Mar 1, 2007ClinicalTrials.gov NCT00589875 · fetched Nov 12, 2026
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant GliomasPHASE1 · COMPLETED · started Nov 1, 2005ClinicalTrials.gov NCT00751270 · fetched Nov 12, 2026

SEC filings12

8-K · 8-KSEC EDGAR · filed Sep 10, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Sep 9, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 24, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Jun 16, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
10-Q · 10-QSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
10-K · 10-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Mar 12, 2026 · fetched Nov 12, 2026
8-K · 8-KSEC EDGAR · filed Feb 23, 2026 · fetched Nov 12, 2026